INTRODUCTION: HIV-distal sensory polyneuropathy (HIV-DSPN) is a common complication of HIV infection, yet race as a potential risk factor is not known. METHODS: Between April and October 2009, as part of the NIH Women's Interagency HIV Study (WIHS), 1414 women, 973 of whom were HIV-infected, were clinically evaluated for peripheral neuropathy. Utilizing available clinical, laboratory, and sociodemographic variables, we conducted a cross-sectional analysis of factors associated with HIV-DSPN. Multivariable logistic regression was used to examine factors independently associated with HIV-DSPN. RESULTS: 36% of HIV-infected women met our definition of HIV-DSPN. 41.3% of African Americans, 34.8% of Whites and 24.7% of Hispanics had DSPN. Age, Hepatitis C-co-infection, and diabetes were each significantly associated with HIV-DSPN. After controlling for age, diabetes, Hepatitis C co-infection, alcohol use, current dideoxy-nucleoside reverse transcriptase inhibitor use, current CD4 count, and plasma HIV viral load, HIV-DSPN was significantly associated with ethnicity; the odds ratio was 1.67 (p=0.001) in African-Americans compared to other racial groups. CONCLUSION: The prevalence of HIV-DSPN in women was lower than reported in prior studies. The likelihood of HIV-DSPN was higher in African-Americans compared to other racial groups. HIV-DSPN was more common in those co-infected with Hepatitis C, older individuals, and diabetics. Further prospective studies are needed to explore the relationship between gender, race, and HIV-DSPN, and the mechanistic basis for racial differences.
INTRODUCTION:HIV-distal sensory polyneuropathy (HIV-DSPN) is a common complication of HIV infection, yet race as a potential risk factor is not known. METHODS: Between April and October 2009, as part of the NIH Women's Interagency HIV Study (WIHS), 1414 women, 973 of whom were HIV-infected, were clinically evaluated for peripheral neuropathy. Utilizing available clinical, laboratory, and sociodemographic variables, we conducted a cross-sectional analysis of factors associated with HIV-DSPN. Multivariable logistic regression was used to examine factors independently associated with HIV-DSPN. RESULTS: 36% of HIV-infectedwomen met our definition of HIV-DSPN. 41.3% of African Americans, 34.8% of Whites and 24.7% of Hispanics had DSPN. Age, Hepatitis C-co-infection, and diabetes were each significantly associated with HIV-DSPN. After controlling for age, diabetes, Hepatitis C co-infection, alcohol use, current dideoxy-nucleoside reverse transcriptase inhibitor use, current CD4 count, and plasma HIV viral load, HIV-DSPN was significantly associated with ethnicity; the odds ratio was 1.67 (p=0.001) in African-Americans compared to other racial groups. CONCLUSION: The prevalence of HIV-DSPN in women was lower than reported in prior studies. The likelihood of HIV-DSPN was higher in African-Americans compared to other racial groups. HIV-DSPN was more common in those co-infected with Hepatitis C, older individuals, and diabetics. Further prospective studies are needed to explore the relationship between gender, race, and HIV-DSPN, and the mechanistic basis for racial differences.
Authors: Jacqueline A Pettersen; Gareth Jones; Catherine Worthington; Hartmut B Krentz; Oliver T Keppler; Ahmet Hoke; M John Gill; Christopher Power Journal: Ann Neurol Date: 2006-05 Impact factor: 10.422
Authors: Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young Journal: Clin Diagn Lab Immunol Date: 2005-09
Authors: Kenneth A Lichtenstein; Carl Armon; Anna Baron; Anne C Moorman; Kathleen C Wood; Scott D Holmberg Journal: Clin Infect Dis Date: 2004-12-06 Impact factor: 9.079
Authors: Scott R Evans; Ronald J Ellis; Huichao Chen; Tzu-min Yeh; Anthony J Lee; Giovanni Schifitto; Kunling Wu; Ronald J Bosch; Justin C McArthur; David M Simpson; David B Clifford Journal: AIDS Date: 2011-04-24 Impact factor: 4.177
Authors: E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur Journal: Neurology Date: 1999-02 Impact factor: 9.910
Authors: K Smyth; J S Affandi; J C McArthur; C Bowtell-Harris; A M Mijch; K Watson; K Costello; I J Woolley; P Price; S L Wesselingh; C L Cherry Journal: HIV Med Date: 2007-09 Impact factor: 3.180
Authors: Antonia L Wadley; Liesl M Hendry; Peter R Kamerman; Constance S N Chew; Patricia Price; Catherine L Cherry; Zané Lombard Journal: Eur J Hum Genet Date: 2014-06-04 Impact factor: 4.246
Authors: D L Hertz; S Roy; A A Motsinger-Reif; A Drobish; L S Clark; H L McLeod; L A Carey; E C Dees Journal: Ann Oncol Date: 2013-02-14 Impact factor: 32.976
Authors: Mary M Mitchell; Trang Q Nguyen; Allysha C Maragh-Bass; Sarina R Isenberg; Mary Catherine Beach; Amy R Knowlton Journal: AIDS Behav Date: 2017-06
Authors: Kristine M Erlandson; Long Zhang; Derek K Ng; Keri N Althoff; Frank J Palella; Lawrence A Kingsley; Lisa P Jacobson; Joseph B Margolick; Jordan E Lake; Todd T Brown Journal: J Acquir Immune Defic Syndr Date: 2019-08-01 Impact factor: 3.731
Authors: Emily R Cedarbaum; Yifei Ma; Adaora A Adimora; Marcas Bamman; Mardge H Cohen; Margaret A Fischl; Deborah Gustafson; Kunihiro Matsushita; Igho Ofotokun; Michael Plankey; Eric C Seaberg; Anjali Sharma; Phyllis C Tien Journal: AIDS Date: 2022-03-01 Impact factor: 4.177
Authors: Daniel L Hertz; Siddharth Roy; John Jack; Alison A Motsinger-Reif; Amy Drobish; L Scott Clark; Lisa A Carey; E Claire Dees; Howard L McLeod Journal: Breast Cancer Res Treat Date: 2014-04-06 Impact factor: 4.872
Authors: Asha R Kallianpur; Mariana Gerschenson; Todd Hulgan; Harpreet Kaur; David B Clifford; David W Haas; Deborah G Murdock; Justin C McArthur; David C Samuels; David M Simpson Journal: AIDS Res Hum Retroviruses Date: 2018-08-22 Impact factor: 2.205